Profitability Ratios
| Ratio |
Value |
| GP Margin |
70.0% |
| EBIT Margin |
11.6% |
| EBITDA Margin |
26.5% |
| Operating Margin |
16.2% |
| Pretax Margin |
6.6% |
| Cont. Ops Margin |
7.6% |
| Net Margin |
7.6% |
| Bottom Line Margin |
7.5% |
Liquidity Ratios
| Ratio |
Value |
| Current Ratio |
0.66 |
| Quick Ratio |
0.55 |
| Solvency Ratio |
0.096 |
| Cash Ratio |
0.14 |
Valuation Ratios
| Ratio |
Value |
| Price/Earnings |
8.37 |
| PEG Ratio |
-0.69 |
| Forward PEG |
-0.69 |
| Price/Book |
10.76 |
| Price/Sales |
0.64 |
| Price/FCF |
2.01 |
| Price/Op Cash Flow |
1.90 |
Debt Ratios
| Ratio |
Value |
| Debt/Assets |
0.4968 |
| Debt/Equity |
20.1937 |
| Debt/Capital |
0.9528 |
| Long-Term Debt/Capital |
0.9478 |
| Financial Leverage |
40.65 |
Cash Flow Ratios
| Ratio |
Value |
| Working Capital Turnover |
-6.26 |
| Operating Cash Flow Ratio |
0.485 |
| Operating Cash Flow/Sales |
33.4% |
| Free Cash Flow/Operating Cash Flow |
94.8% |
Coverage Ratios
| Ratio |
Value |
| Debt Service Coverage |
1.61 |
| Interest Coverage |
3.2539 |
| Short-Term Operating Cash Flow Coverage |
2.76 |
| Operating Cash Flow Coverage |
0.28 |
| Capital Expenditure Coverage |
19.31 |
| Dividend + Capital Expenditure Coverage |
1.57 |
Dividend Ratios
| Ratio |
Value |
| Payout Ratio |
257.7139% |
| Dividend Yield |
30.8072% |
| Dividend Yield % |
30.8072% |
| Dividend Per Share |
6.2455 |
Per Share Ratios
| Ratio |
Value |
| Revenue/Share |
31.91 |
| EPS |
2.423 |
| Debt/Share |
39.6271 |
| Cash/Share |
3.15 |
| Book Value/Share |
1.91 |
| Tangible BV/Share |
-51.92 |
| Equity/Share |
1.88 |
| Operating Cash Flow/Share |
10.653 |
| Capital Expenditure/Share |
0.552 |
| FCF/Share |
10.102 |
Other Ratios
| Ratio |
Value |
| Net Income/Earnings Before Tax |
1.151 |
| Earnings Before Tax/EBIT |
0.407 |
| Price/Fair Value |
10.76 |
| Debt/Market Cap |
1.8762 |
| Effective Tax Rate |
-15.3% |
| Enterprise Value Multiple |
6.53 |
ABBV.BA - AbbVie Inc.